Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aura Biosciences Prepares To Move Nano-Enabled Drug Delivery System Into The Clinic

This article was originally published in The Pink Sheet Daily

Executive Summary

Biotech's nanotechnology platform enables earlier detection of cancers and distant metastases, as well as targeted drug delivery.
Advertisement

Related Content

In Oncology Drug Boom, Can Next-Gen Cytotoxics Fit In?
No Big Surprises From Lilly: Management Sticks To Its Guns On Strategy
Amgen Takes Out Cancer Vaccine Developer BioVex In Potential $1B Deal
Amgen Takes Out Cancer Vaccine Developer BioVex In Potential $1B Deal

Topics

Advertisement
UsernamePublicRestriction

Register

PS072761

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel